Farallon Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-55,000	Closed	-$22.4M	–	186
2023 Q4	$22.4M	Sell	55,000 -147,000	-73%	-$59.8M	0.1%	66
2023 Q3	$70.2M	Buy	+202,000	New	+$70.2M	0.33%	50